PLDL1 Polyclonal Antibody, PE Conjugated
Product Specifications
Background
PLCL1 is involved an inositol phospholipid based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and sphatidylinositol. Component in the dependent endocytosis process of GABA A receptor (By similarity) . Regulates the turnover of receptors and thus contributes to the maintenance of GABA mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C.
Synonyms
PLCL1; PLCE; Phospholipase C deleted in lung carcinoma; Phospholipase C epsilon; Phospholipase C like 1; Phospholipase C related but catalytically inactive protein; Phospholipase C related, but catalytically inactive protein; PLCE; PLCL; PRIP; Plcl1; C230017K02Rik; KIAA1092; PLC-L; PLC-L1; PLCE; PLCL; PRIP; PRIP-1; PLCL1_HUMAN.
Gene ID
5334
Cellular Locus
Cytoplasm
Host
Rabbit
Immunogen
1001-1096/1096
Target
PLDL1
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE
Source
KLH conjugated synthetic peptide derived from human PLCL1
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
496,564nm/578nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Specificity
This antibody may exhibit a slight secondary cross-reactivity with PLCL2 due to a 69% non-sequential sequence similarity over the immunogen range.
Gene ID URL
5334
Predicted Cross Reactivity
Human, Mouse, Rat, Dog, Cow, Pig, Horse
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7078946 Inquire
Recombinant Shigella sonnei L-tartrate/succinate antiporter (ttdT), partial
Ask
View Details 
